DE602006013809D1 - Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden - Google Patents
Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine bindenInfo
- Publication number
- DE602006013809D1 DE602006013809D1 DE602006013809T DE602006013809T DE602006013809D1 DE 602006013809 D1 DE602006013809 D1 DE 602006013809D1 DE 602006013809 T DE602006013809 T DE 602006013809T DE 602006013809 T DE602006013809 T DE 602006013809T DE 602006013809 D1 DE602006013809 D1 DE 602006013809D1
- Authority
- DE
- Germany
- Prior art keywords
- antibody
- scfv
- bind
- post
- translationally modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06291195A EP1882697B1 (de) | 2006-07-24 | 2006-07-24 | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006013809D1 true DE602006013809D1 (de) | 2010-06-02 |
Family
ID=37075006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006013809T Active DE602006013809D1 (de) | 2006-07-24 | 2006-07-24 | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden |
Country Status (11)
Country | Link |
---|---|
US (2) | US20100055109A1 (de) |
EP (2) | EP1882697B1 (de) |
JP (1) | JP5528803B2 (de) |
AR (1) | AR062038A1 (de) |
AT (1) | ATE465179T1 (de) |
BR (1) | BRPI0714545A2 (de) |
CA (1) | CA2657563A1 (de) |
DE (1) | DE602006013809D1 (de) |
HK (1) | HK1116806A1 (de) |
UY (1) | UY30501A1 (de) |
WO (1) | WO2008012049A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602006013809D1 (de) * | 2006-07-24 | 2010-06-02 | Facultad De Medicina Universid | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden |
WO2012033916A1 (en) * | 2010-09-08 | 2012-03-15 | Southern Illinois University Edwardsville | Method for treating chronic pain |
US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
AU2011336470B8 (en) | 2010-12-01 | 2017-09-14 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
GB201214007D0 (en) * | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
US20180236031A1 (en) * | 2017-02-10 | 2018-08-23 | Vivibaba, Inc | Compositions and methods for recombinant nerve growth factor |
CA3095125A1 (en) * | 2018-03-27 | 2019-10-03 | Factor Bioscience Inc. | Nucleic acid-based therapeutics |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
JPS58201994A (ja) | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | 抗原特異的ヒト免疫グロブリンの生産方法 |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5994524A (en) | 1994-07-13 | 1999-11-30 | Chugai Seiyaku Kabushiki Kaisha | Polynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the same |
US6068040A (en) | 1998-07-24 | 2000-05-30 | Alpine Overhead Doors, Inc. | Slat edge retainer for overhead rolling doors |
EP1500399A1 (de) * | 2003-07-24 | 2005-01-26 | Institut Pasteur | Aktive und passive Immunisierung gegen pro-apoptotischen Neurotrophinen zur Behandlung oder Vorbeugung von neurologischen Krankheiten |
DE602006013809D1 (de) * | 2006-07-24 | 2010-06-02 | Facultad De Medicina Universid | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden |
-
2006
- 2006-07-24 DE DE602006013809T patent/DE602006013809D1/de active Active
- 2006-07-24 AT AT06291195T patent/ATE465179T1/de not_active IP Right Cessation
- 2006-07-24 EP EP06291195A patent/EP1882697B1/de not_active Not-in-force
-
2007
- 2007-07-23 CA CA002657563A patent/CA2657563A1/en not_active Abandoned
- 2007-07-23 JP JP2009521157A patent/JP5528803B2/ja not_active Expired - Fee Related
- 2007-07-23 BR BRPI0714545-4A patent/BRPI0714545A2/pt not_active IP Right Cessation
- 2007-07-23 EP EP07786268A patent/EP2046823B1/de not_active Not-in-force
- 2007-07-23 US US12/374,485 patent/US20100055109A1/en not_active Abandoned
- 2007-07-23 WO PCT/EP2007/006528 patent/WO2008012049A1/en active Application Filing
- 2007-07-24 AR ARP070103275A patent/AR062038A1/es unknown
- 2007-07-24 UY UY30501A patent/UY30501A1/es not_active Application Discontinuation
-
2008
- 2008-07-08 HK HK08107507.3A patent/HK1116806A1/xx not_active IP Right Cessation
-
2013
- 2013-09-26 US US14/037,973 patent/US9328163B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
HK1116806A1 (en) | 2009-01-02 |
UY30501A1 (es) | 2009-04-30 |
US9328163B2 (en) | 2016-05-03 |
JP2010501475A (ja) | 2010-01-21 |
ATE465179T1 (de) | 2010-05-15 |
WO2008012049A1 (en) | 2008-01-31 |
CA2657563A1 (en) | 2008-01-31 |
US20100055109A1 (en) | 2010-03-04 |
AR062038A1 (es) | 2008-08-10 |
EP2046823A1 (de) | 2009-04-15 |
US20140178384A1 (en) | 2014-06-26 |
BRPI0714545A2 (pt) | 2013-05-14 |
EP1882697A1 (de) | 2008-01-30 |
EP1882697B1 (de) | 2010-04-21 |
EP2046823B1 (de) | 2012-11-21 |
JP5528803B2 (ja) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006013809D1 (de) | Antikörper, Antikörperfragmente und scFv die an posttranslational modifizierte Neurotrophine binden | |
CY2019004I2 (el) | Τροποποιημενα αντισωματα αντι-ιl-23ρ19 | |
BRPI0822447A2 (pt) | Anticorpo monoclonal e método do mesmo | |
HRP20150074T1 (hr) | Humana antitijela koja se vežu za mezotelin i njihove uporabe | |
IL198592A0 (en) | Tes7 and antibodies that bind thereto | |
EP2322562A4 (de) | Monoklonaler antikörper und immunassay damit | |
ZA201003496B (en) | Monoclonal antibody capable of binding to anexelekto,and use thereof | |
SI2510011T1 (sl) | Monoklonska protitelesa, ki veĹľejo B7H6 in njihova uporaba | |
NO344963B1 (no) | Humanisert antistoff | |
DK2225280T3 (da) | Bivalente, bispecifikke antistoffer | |
BRPI0821375A2 (pt) | Anticorpos biespecíficos, bivalentes | |
BRPI0821405A2 (pt) | Anticorpos biespecíficos, bivalentes | |
IL197928A (en) | A monoclonal antibody munched on steap-1, its immunoconjugates its uses | |
BRPI1014089A2 (pt) | anticorpos multiespecíficos que compreendem anticorpos de comprimento completo e fragmentos fab de cadeia simples | |
IL194995A0 (en) | Modified humanised anti-interleukin-18 antibodies | |
DK1994055T3 (da) | Anti-5t4-antistoffer og anvendelser deraf | |
FI20075278A0 (fi) | Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet | |
BRPI0820298A8 (pt) | composições e métodos de anticorpos anti-vegf | |
BRPI0809677A2 (pt) | Anticorpos anti-ige | |
BRPI0720218A2 (pt) | Anticorpos monoclonais contra angptl3 | |
BRPI0918178A2 (pt) | anticorpos monoclonais para tratamento de câncer | |
SG10201601279SA (en) | Monoclonal Antibody STRO-4 | |
EP2006379A4 (de) | Hochfunktioneller bispezifischer antikörper | |
FI20070853A0 (fi) | Glykaania sitovat monoklonaaliset vasta-aineet | |
BRPI0814111A2 (pt) | Anticorpo monoclonal citotóxico anticâncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: INSTITUT PASTEUR, PARIS, FR Owner name: FACULTAD DE MEDICINA, UNIVERSIDAD DE LA REPUBL, UY Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR Owner name: INSTITUTO DE INVESTIGACIONES BIOLOGICAS CLEMEN, UY |
|
8364 | No opposition during term of opposition |